Jasnervoside C is primarily investigated for its potential anti-inflammatory and neuroprotective properties. It has shown promise in preclinical studies targeting neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases by modulating oxidative stress and inhibiting key inflammatory pathways in neural tissues. Its ability to cross the blood-brain barrier enhances its suitability for central nervous system therapies. Additionally, jasnervoside C exhibits cytotoxic activity against certain cancer cell lines, suggesting possible use in oncology, particularly in the development of novel chemotherapeutic agents. Research is ongoing to evaluate its bioavailability and long-term safety for therapeutic applications.